|
Market Closed -
Nasdaq
20:00:00 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 70.11 USD | -14.03% |
|
-2.01% | +329.86% |
| 10-23 | Stephens Downgrades 10x Genomics to Equal Weight From Overweight, $65 Price Target | MT |
| 10-09 | BofA Securities Adjusts 10x Genomics Price Target to $80 From $50 | MT |
| Market Cap | 9.13B 8.18B 7.53B 6.82B 12.75B 867B 12.98B 89.74B 36.02B 456B 34.28B 33.55B 1,439B | P/E 2026 * |
-95.9x | P/E 2027 * | -99.6x |
|---|---|---|---|---|---|
| Enterprise Value | 8.69B 7.78B 7.16B 6.49B 12.13B 825B 12.35B 85.37B 34.27B 434B 32.61B 31.92B 1,369B | EV / Sales 2026 * |
14x | EV / Sales 2027 * | 12.6x |
| Free-Float |
90.93% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TXG | Delayed | |
CBOE
| TXG | Real-time | |
Tradegate
| 1KJ | Real-time | |
Boerse Muenchen
| 1KJ | Real-time | |
London S.E.
| 0A88 | Delayed | |
Börse Stuttgart
| 1KJ | Delayed | |
Deutsche Boerse AG
| 1KJ | Delayed | |
Mexican S.E.
| TXG * | End-of-day quote | |
Xetra
| 1KJ | Delayed |
Last Transcript: 10x Genomics, Inc.
| 1 day | -14.03% | ||
| 1 week | -2.01% | ||
| Current month | -22.41% | ||
| 1 month | -22.41% | ||
| 3 months | +41.84% | ||
| 6 months | +217.96% | ||
| Current year | +329.86% |
| 1 week | 67.42 | 87.82 | |
| 1 month | 67.25 | 102.81 | |
| Current year | 15.9 | 102.81 | |
| 1 year | 12.8 | 102.81 | |
| 3 years | 6.78 | 102.81 | |
| 5 years | 6.78 | 187.85 | |
| 10 years | 6.78 | 208.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Serge Saxonov
CEO | Chief Executive Officer | 49 | 01/07/2012 |
Ben Hindson
PSD | President | 51 | 30/09/2012 |
Adam Taich
DFI | Director of Finance/CFO | 51 | 11/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Ben Hindson
BRD | Director/Board Member | 51 | 01/07/2012 |
Serge Saxonov
BRD | Director/Board Member | 49 | 01/07/2012 |
John Stuelpnagel
CHM | Chairman | 68 | 31/07/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 22/09/26 | Sell | Director | -5,723 | 0.0048% | ||
| 22/09/26 | Sell | Founder | -25,000 | 0.0208% | ||
| 09/09/26 | Sell | Chief Financial Officer | -46,388 | 0.0386% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -14.03% | -2.01% | +463.59% | +96.11% | 9.13B | ||
| +1.56% | +2.41% | -14.82% | +14.19% | 184B | ||
| -6.38% | -4.98% | -20.90% | +11.15% | 112B | ||
| -0.59% | +1.18% | +6.12% | +37.97% | 118B | ||
| +3.42% | +1.71% | -42.32% | +9.52% | 94.58B | ||
| +0.09% | -0.05% | -3.04% | +78.44% | 63.13B | ||
| -0.46% | +0.42% | +8.19% | +82.97% | 55.66B | ||
| -0.23% | -0.52% | +10.31% | -21.19% | 53.9B | ||
| -4.30% | -1.64% | -12.30% | +39.06% | 43.42B | ||
| +0.58% | +2.00% | -1.07% | -6.43% | 34.68B | ||
| Average | -2.03% | -0.15% | +39.38% | +34.18% | 76.84B | |
| Weighted average by Cap. | -0.65% | +0.21% | -5.02% | +26.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 621M 556M 511M 463M 866M 58.92B 882M 6.1B 2.45B 31B 2.33B 2.28B 97.75B | 683M 612M 563M 510M 953M 64.88B 971M 6.71B 2.69B 34.13B 2.56B 2.51B 108B |
| Net income | -95.86M -85.85M -78.97M -71.55M -134M -9.1B -136M -942M -378M -4.79B -360M -352M -15.1B | -90.23M -80.81M -74.33M -67.35M -126M -8.57B -128M -886M -356M -4.51B -339M -331M -14.21B |
| Net Debt | -445M -398M -366M -332M -620M -42.21B -632M -4.37B -1.75B -22.2B -1.67B -1.63B -70.03B | -527M -472M -434M -393M -735M -50.01B -749M -5.17B -2.08B -26.31B -1.98B -1.93B -82.97B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | US$70.11 | -14.03% | 5,218,776 |
| 29/10/26 | US$81.55 | -2.48% | 1,860,047 |
| 28/10/26 | US$83.62 | +7.18% | 5,047,435 |
| 27/10/26 | US$78.02 | +6.94% | 2,129,136 |
| 26/10/26 | US$72.96 | +1.97% | 1,413,121 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TXG Stock
Select your edition
All financial news and data tailored to specific country editions

















